The Union Cabinet today gave its approval for signing the Agreement in the field of Vaccine Research by India and International Institute of Vaccine, Seoul, Korea.
International Vaccine Institute (IVI), with headquarters at Seoul, South Korea is an autonomous organization set up at the initiative of the united Nations Development Programme under the Vienna Convention of 1969. IVI is an international center of research, training & technical assistance for vaccine production in developing countries.
The Agreement shall encourage cooperation between India and the international Vaccine Institute. By the agreement, India could offer a place on Board of Trustees, and would be able to play a role in formulation of international policy related to vaccines.
Signatories to the IVI Establishment Agreement as of March 2002 are Republic of Korea, China, Brazil, Egypt, Pakistan, Netherlands, Sri Lanka, Sweden, Bangladesh, Bhutan, Ecuador, Indonesia, Israel, Jamaica, Kazakhstan, Kyrgyzstan, Lebanon, Malta, Mongolia, Myanmar, Nepal, Oman, Panama Papua New Guinea, Peru, Philippines, Romania, Senegal, Tajikistan, Thailand, Turkey, Uzbekistan, Vietnam and World Health Organization.
The signing of the Agreement does not have any financial implication for the Government of India. On the other hand, it will give opportunities for inputs to the direction and priorities of IVI, which would be beneficial to India.
****
DS/LV
(Release ID :26837)